mitoxantrone has been researched along with Hyperpigmentation in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reinsberger, C | 1 |
| Meuth, SG | 1 |
| Wiendl, H | 1 |
1 other study available for mitoxantrone and Hyperpigmentation
| Article | Year |
|---|---|
Dose-dependent melanonychia by mitoxantrone.
Topics: Adult; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperpigmentation; I | 2009 |